KEGG   PATHWAY: pteh04934
Entry
pteh04934                   Pathway                                
Name
Cushing syndrome - Piliocolobus tephrosceles (Ugandan red Colobus)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
pteh04934  Cushing syndrome
pteh04934

Organism
Piliocolobus tephrosceles (Ugandan red Colobus) [GN:pteh]
Gene
111549267  CRH; corticoliberin [KO:K05256]
111529275  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
111523626  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
111555637  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoform X6 [KO:K04632]
111555638  neuroendocrine secretory protein 55 [KO:K04632]
111546755  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
111554419  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
111552878  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
111544335  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
111542054  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
111541238  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
111549769  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
111551667  ADCY9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
111523821  PRKACA; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
111543418  PRKACG; cAMP-dependent protein kinase catalytic subunit gamma isoform X1 [KO:K04345] [EC:2.7.11.11]
111540404  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
111547676  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
111542753  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
111548140  cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
111548991  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
111521981  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
111543707  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 [KO:K09048]
111544982  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
111536760  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
111524755  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
111551841  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
111528965  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
111522336  MEN1; menin isoform X1 [KO:K14970]
111544130  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
111522724  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
111523995  WDR5; WD repeat-containing protein 5 [KO:K14963]
111544213  WDR5B; WD repeat-containing protein 5B [KO:K14963]
111540209  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
111542040  KMT2D; histone-lysine N-methyltransferase 2D isoform X1 [KO:K09187] [EC:2.1.1.354]
111524037  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
111537212  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
111541790  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
111552475  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
111522272  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
111523077  RB1; retinoblastoma-associated protein [KO:K06618]
111548151  E2F1; transcription factor E2F1 [KO:K17454]
111547703  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
111541114  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
111526168  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
111552452  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
111555442  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
111556065  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
111545034  AHR; aryl hydrocarbon receptor [KO:K09093]
111527932  LOW QUALITY PROTEIN: uncharacterized protein LOC111527932 [KO:K09093]
111521362  AIPL1; aryl-hydrocarbon-interacting protein-like 1 isoform X1 [KO:K17767]
111522218  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
111543620  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
111552085  CDKN1B; cyclin-dependent kinase inhibitor 1B isoform X1 [KO:K06624]
111541872  CDK2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
111553938  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
111549709  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
111542983  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
111520328  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C [KO:K04850]
111524370  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
111550963  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
111552236  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
111552636  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
111537843  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
111547908  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
111556041  RAP1A; ras-related protein Rap-1A isoform X1 [KO:K04353]
111528626  RAP1B; ras-related protein Rap-1b [KO:K07836]
111532119  ras-related protein Rap-1b [KO:K07836]
111521522  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
111548354  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
111521954  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
111530673  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
111525729  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
111541979  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
111555709  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
111552737  USP8; LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 8 [KO:K11839] [EC:3.4.19.12]
111554491  POMC; pro-opiomelanocortin [KO:K05228]
111553619  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
111525089  MRAP; melanocortin-2 receptor accessory protein isoform X1 [KO:K22398]
111544409  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B [KO:K18437] [EC:3.1.4.53]
111522891  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
111542770  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform X1 [KO:K13298] [EC:3.1.4.17 3.1.4.35]
111545972  NR5A1; steroidogenic factor 1 [KO:K08560]
111541933  transcription factor Sp1 isoform X1 [KO:K04684]
111539276  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
111535654  LOW QUALITY PROTEIN: cytochrome P450 11B1, mitochondrial-like [KO:K00497] [EC:1.14.15.4]
111538851  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
111544129  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
111543474  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
111525632  ARMC5; armadillo repeat-containing protein 5 isoform X1 [KO:K22499]
111533277  AGT; angiotensinogen [KO:K09821]
111544725  AGTR1; type-1 angiotensin II receptor isoform X1 [KO:K04166]
111543374  guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
111520693  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
111546451  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 [KO:K05858] [EC:3.1.4.11]
111522292  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
111524236  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
111546452  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
111546970  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
111540617  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
111543148  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
111537013  KCNK2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
111537578  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
111524152  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H [KO:K04855]
111549100  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I [KO:K04856]
111538017  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
111554702  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
111554476  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
111527714  LDLR; low-density lipoprotein receptor [KO:K12473]
111552064  SCARB1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
111529691  cholesterol side-chain cleavage enzyme, mitochondrial isoform X1 [KO:K00498] [EC:1.14.15.6]
111549591  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
111549589  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1-like isoform X1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
111526288  steroid 21-hydroxylase isoform X1 [KO:K00513] [EC:1.14.14.16]
111545225  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
111542045  WNT1; proto-oncogene Wnt-1 [KO:K03209]
111553419  WNT2; protein Wnt-2 [KO:K00182]
111556053  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
111528374  WNT3; proto-oncogene Wnt-3 [KO:K00312]
111536986  WNT3A; protein Wnt-3a [KO:K00312]
111547777  WNT4; protein Wnt-4 [KO:K00408]
111520300  WNT5B; protein Wnt-5b [KO:K00444]
111524378  WNT5A; protein Wnt-5a [KO:K00444]
111546073  WNT6; protein Wnt-6 [KO:K00445]
111529314  WNT7A; protein Wnt-7a [KO:K00572]
111549155  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
111538807  WNT8B; protein Wnt-8b [KO:K00714]
111527470  WNT8A; protein Wnt-8a isoform X1 [KO:K00714]
111528375  WNT9B; protein Wnt-9b isoform X1 [KO:K01064]
111537061  WNT9A; protein Wnt-9a [KO:K01064]
111542044  WNT10B; protein Wnt-10b [KO:K01357]
111546079  WNT10A; protein Wnt-10a [KO:K01357]
111540697  WNT11; protein Wnt-11 [KO:K01384]
111550237  protein Wnt-16 [KO:K01558]
113224821  protein Wnt-16 [KO:K01558]
111552479  FZD1; frizzled-1 [KO:K02432]
111545811  FZD7; frizzled-7 [KO:K02432]
111525827  FZD2; frizzled-2 [KO:K02235]
111545779  FZD3; frizzled-3 [KO:K02329]
111540757  FZD4; frizzled-4 [KO:K02354]
111546690  FZD8; frizzled-8 [KO:K02375]
111547737  FZD5; frizzled-5 [KO:K02375]
111551484  FZD6; frizzled-6 [KO:K02376]
111522969  FZD10; frizzled-10 [KO:K02842]
111547022  FZD9; frizzled-9 [KO:K02842]
111523166  DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
111521282  DVL2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
111526841  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
111543871  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
111524116  AXIN1; axin-1 [KO:K02157]
111542510  AXIN2; axin-2 isoform X1 [KO:K04385]
111555526  CTNNB1; catenin beta-1 [KO:K02105]
111542693  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
111534247  adenomatous polyposis coli protein 2 [KO:K02085]
111529175  TCF7; transcription factor 7 isoform X1 [KO:K02620]
111551134  TCF7L1; transcription factor 7-like 1 [KO:K04490]
111538904  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
111547880  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
pteh00020  Citrate cycle (TCA cycle)
pteh00140  Steroid hormone biosynthesis
pteh04020  Calcium signaling pathway
pteh04024  cAMP signaling pathway
pteh04110  Cell cycle
pteh04310  Wnt signaling pathway
pteh04927  Cortisol synthesis and secretion
pteh04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system